Literature DB >> 10450555

19th Meeting of the European Neurological Society. Milan, Italy, 5-9 June 1999. Abstracts.

.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10450555      PMCID： PMC7088054          DOI： 10.1007/bf03160586

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  13 in total

1.  Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke.

Authors:  E Mori; Y Yoneda; M Tabuchi; T Yoshida; S Ohkawa; Y Ohsumi; K Kitano; A Tsutsumi; A Yamadori
Journal:  Neurology       Date:  1992-05       Impact factor: 9.910

2.  Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease.

Authors:  W Hacke; H Zeumer; A Ferbert; H Brückmann; G J del Zoppo
Journal:  Stroke       Date:  1988-10       Impact factor: 7.914

3.  Trials of streptokinase in severe acute ischaemic stroke.

Authors:  G A Donnan; S M Davis; B R Chambers; P C Gates; G J Hankey; J J McNeil; D Rosen; E G Stewart-Wynne; R R Tuck
Journal:  Lancet       Date:  1995-03-04       Impact factor: 79.321

4.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

Review 5.  Comparative tolerability profiles of thrombolytic agents. A review.

Authors:  K S Woo; H D White
Journal:  Drug Saf       Date:  1993-01       Impact factor: 5.606

6.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Authors:  W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas
Journal:  Lancet       Date:  1998-10-17       Impact factor: 79.321

7.  Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk.

Authors:  R von Kummer; U Meyding-Lamadé; M Forsting; L Rosin; K Rieke; W Hacke; K Sartor
Journal:  AJNR Am J Neuroradiol       Date:  1994-01       Impact factor: 3.825

8.  Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

Authors:  W Hacke; M Kaste; C Fieschi; D Toni; E Lesaffre; R von Kummer; G Boysen; E Bluhmki; G Höxter; M H Mahagne
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

9.  Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group.

Authors: 
Journal:  Lancet       Date:  1995-12-09       Impact factor: 79.321

Review 10.  Thrombolytic therapy for acute ischemic stroke.

Authors:  E C Haley
Journal:  Clin Neuropharmacol       Date:  1993-06       Impact factor: 1.592
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.